Florida-based biotech company Soilcea developed CarriCea T1, a Carrizo orange variety that is resistant to HLB, also known as ...

Dr. Swee Lay Thein and Dr. Stuart Orkin won the $3 million Breakthrough Prize in Life Sciences for their work toward a ...

Intellia Therapeutics reported that its in vivo CRISPR therapy, lonvo-z, met all endpoints in a Phase 3 trial for hereditary angioedema, with 62% of patients attack-free versus 11% on placebo. The one ...

Intellia Therapeutics reported that its in vivo CRISPR therapy, lonvo-z, met all primary and secondary endpoints in a Phase 3 ...

National Institutes of Health (NIH) released the following: A National Institutes of Health (NIH)-funded research team has ...

Researchers have developed a modified CRISPR gene-editing tool with potential to silence the extra chromosome causing Down ...

(Nanowerk News) In a major step forward for cancer care, researchers at ChristianaCare’s Gene Editing Institute have shown that disabling the NRF2 gene with CRISPR technology can reverse chemotherapy ...

Torie Bosch is the First Opinion editor at STAT. Celena Lozano’s son Benny, who turned 5 in November, loves trains, trucks — anything that goes. He also has a rare disease, PURA syndrome. Earlier this ...

Rice (Oryza sativa L.) feeds over half of the global population and is central to food security across Asia, Africa, and the Americas. To meet the world’s growing demand, breeders are pursuing ideal ...

Scientists have taken an important step toward a gene therapy that could one day turn off the extra genetic material that ...